President & CEO Hua Medicine
Dr Li Chen is the co-founder and CEO of Hua Medicine, a Chinese biotech company focuses on discovery, development and commercialization of clinically differentiated medicines for worldwide unmet medical needs. Hua Medicine currently has world-wide rights to two novel assets. The most advanced program is a first-in-class, oral drug for the treatment of Type 2 Diabetes currently in Phase 2 trials in China. Before Li started Hua Medicine, he was the Chief Scientific Officer at Roche R&D China and a member of Roche Pharma Research Leadership Team. He was an adjunct professor at Tongji University. Li obtained a master’s degree in 1985 from East China Normal University in Shanghai where he also gave lectures in Organic and Synthetic Organic Chemistry. Li completed his university education with a Ph.D. in Organic Chemistry from Iowa State University in the United States in 1992.